Sernova Biotherapeutics Inc
SEOVF
$0.1422
$0.01249.55%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.09M | 6.60M | 6.73M | 6.56M | 7.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.25M | 23.30M | 28.57M | 31.05M | 31.07M |
| Operating Income | -19.25M | -23.30M | -28.57M | -31.05M | -31.07M |
| Income Before Tax | -20.47M | -23.68M | -28.67M | -30.61M | -30.18M |
| Income Tax Expenses | 9.60K | 5.10K | -- | -- | -- |
| Earnings from Continuing Operations | -20.48 | -23.69 | -28.67 | -30.61 | -30.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.48M | -23.69M | -28.67M | -30.61M | -30.18M |
| EBIT | -19.25M | -23.30M | -28.57M | -31.05M | -31.07M |
| EBITDA | -19.00M | -23.00M | -28.31M | -30.80M | -30.77M |
| EPS Basic | -0.07 | -0.08 | -0.09 | -0.10 | -0.10 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 |
| EPS Diluted | -0.07 | -0.08 | -0.09 | -0.10 | -0.10 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 1.25B | 1.23B | 1.21B | 1.21B | 1.21B |
| Average Diluted Shares Outstanding | 1.25B | 1.23B | 1.21B | 1.21B | 1.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |